Bromoacetamide-PEG4-DBCO

• Description:

  Bromoacetamide-PEG4-DBCO (Compound bromoacetamido-dPEG ®4-amido-DBCO) is a ADC linker and can be used for synthesis of antibody-drug conjugates (ADCs) [1].

• UNSPSC:

  12352005

• Target:

  ADC Linker

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Field of Research:

  Cancer

• Smiles:

  O=C(CBr)NCCOCCOCCOCCOCCC(NCCC(N1C2=C(C#CC3=C(C1)C=CC=C3)C=CC=C2)=O)=O

• Molecular Formula:

  C31H38BrN3O7

• Molecular Weight:

  644.55

• References & Citations:

  [1]George William FOOT, et al. Compositions containing nucleic acid nanoparticles and processes related to alteration of their physicochemical characteristics. WO2022219409A2. 2023-10-15

• Shipping Conditions:

  Room temperature

• Scientific Category:

  ADC Related

• Clinical Information:

  No Development Reported

• CAS Number:

  [2735663-70-2]